By Bhanvi Satija and Maggie Fick LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

Researchers at Boston University’s Structural Bioinformatics Lab are working with Mercury Computer Systems to develop a system that will make it easier for pharmaceutical companies to develop new ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...

Noor is a clinical researcher with advanced training from Harvard who serves as a clinical trial lead for studies at Amicis Clinical Trials. For decades, the pharmaceutical industry’s approach to ...

A new type of tissue model that more accurately mimics the architecture of the liver could help develop drugs to treat MASLD.

Patients living with severe chronic pain don’t only have to manage a debilitating affliction. They also have to deal with the FDA making it harder for them to access potentially life-changing new ...